Details for Patent: RE49556
✉ Email this page to a colleague
Which drugs does patent RE49556 protect, and when does it expire?
Patent RE49556 protects BRAFTOVI and is included in one NDA.
This patent has seventy-five patent family members in forty-nine countries.
Drugs Protected by US Patent RE49556
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Array Biopharma Inc | BRAFTOVI | encorafenib | CAPSULE;ORAL | 210496-002 | Jun 27, 2018 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent RE49556
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2470526 | ⤷ Sign Up | PA2019005 | Lithuania | ⤷ Sign Up |
| European Patent Office | 2727918 | ⤷ Sign Up | PA2019006 | Lithuania | ⤷ Sign Up |
| European Patent Office | 2470526 | ⤷ Sign Up | 300973 | Netherlands | ⤷ Sign Up |
| European Patent Office | 2727918 | ⤷ Sign Up | 300975 | Netherlands | ⤷ Sign Up |
| European Patent Office | 2470526 | ⤷ Sign Up | LUC00101 | Luxembourg | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
